Tousignant Jennifer
Chief Legal Officer
Exercise
Calculated transaction value
$144.1K
10,000 shares @ $14.41
Traded
Aug 19, 2026
Filed
Aug 20, 2026
You're reading the free version. Trader adds the live tape and alerts.
Start tracking
Viridian Therapeutics
VRDN
ManufacturingChemicals
Transactions reported in official disclosures
Price with disclosed trades
Daily closes, past year · marks sit on transaction dates, sized by value
12 trades
| Reporting person | Filed | Transaction | Transaction value | Source | Actions |
|---|---|---|---|---|---|
| Tousignant Jennifer Chief Legal Officer | Aug 20, 2026 1-day lag | Exercise Aug 19, 2026 | $144.1K Filed shares x price | SEC Form 4 View filing | |
| Tousignant Jennifer Chief Legal Officer | Aug 20, 2026 1-day lag | Sale Aug 19, 2026 | $245K Filed shares x price | SEC Form 4 View filing | |
| Tousignant Jennifer Chief Legal Officer | Aug 20, 2026 1-day lag | Exercise Aug 19, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Tousignant Jennifer Chief Legal Officer | Aug 20, 2026 1-day lag | Sale Aug 19, 2026 | $103.19K Filed shares x price | SEC Form 4 View filing | |
| Tripuraneni Radhika Chief Medical Officer | Aug 18, 2026 4-day lag | Exercise Aug 14, 2026 | $528.4K Filed shares x price | SEC Form 4 View filing | |
| Tripuraneni Radhika Chief Medical Officer | Aug 18, 2026 4-day lag | Exercise Aug 14, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Morris Arlene Director | Jul 2, 2026 1-day lag | Award Jul 1, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Kiselak Tomas Director | Jul 2, 2026 1-day lag | Award Jul 1, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Gheuens Sarah Director | Jul 2, 2026 1-day lag | Award Jul 1, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Cain Christopher W. Director | Jul 2, 2026 1-day lag | Award Jul 1, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Ajer Jeffrey Robert Director | Jul 2, 2026 1-day lag | Award Jul 1, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Moses Jennifer K. Director | Jul 2, 2026 1-day lag | Award Jul 1, 2026 | $0 Filed shares x price | SEC Form 4 View filing |
Tousignant Jennifer
Chief Legal Officer
Sale
Calculated transaction value
$245K
10,000 shares @ $24.5
Traded
Aug 19, 2026
Filed
Aug 20, 2026
Tousignant Jennifer
Chief Legal Officer
Exercise
Calculated transaction value
$0
10,000 shares @ $0
Traded
Aug 19, 2026
Filed
Aug 20, 2026
Tousignant Jennifer
Chief Legal Officer
Sale
Calculated transaction value
$103.19K
4,212 shares @ $24.5
Traded
Aug 19, 2026
Filed
Aug 20, 2026
Tripuraneni Radhika
Chief Medical Officer
Exercise
Calculated transaction value
$528.4K
40,000 shares @ $13.21
Traded
Aug 14, 2026
Filed
Aug 18, 2026
Tripuraneni Radhika
Chief Medical Officer
Exercise
Calculated transaction value
$0
40,000 shares @ $0
Traded
Aug 14, 2026
Filed
Aug 18, 2026
Morris Arlene
Director
Award
Calculated transaction value
$0
32,341 shares @ $0
Traded
Jul 1, 2026
Filed
Jul 2, 2026
Kiselak Tomas
Director
Award
Calculated transaction value
$0
32,341 shares @ $0
Traded
Jul 1, 2026
Filed
Jul 2, 2026
Gheuens Sarah
Director
Award
Calculated transaction value
$0
32,341 shares @ $0
Traded
Jul 1, 2026
Filed
Jul 2, 2026
Cain Christopher W.
Director
Award
Calculated transaction value
$0
32,341 shares @ $0
Traded
Jul 1, 2026
Filed
Jul 2, 2026
Ajer Jeffrey Robert
Director
Award
Calculated transaction value
$0
32,341 shares @ $0
Traded
Jul 1, 2026
Filed
Jul 2, 2026
Moses Jennifer K.
Director
Award
Calculated transaction value
$0
32,341 shares @ $0
Traded
Jul 1, 2026
Filed
Jul 2, 2026